ketamine hydrochloride
Generic: ketamine hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
ketamine hydrochloride
Generic Name
ketamine hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION
Routes
Active Ingredients
ketamine hydrochloride 100 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65219-186
Product ID
65219-186_9acdebb0-6e88-42b2-ac45-da51aaad0f3c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215808
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2023-07-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65219186
Hyphenated Format
65219-186
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ketamine hydrochloride (source: ndc)
Generic Name
ketamine hydrochloride (source: ndc)
Application Number
ANDA215808 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/mL
Packaging
- 10 VIAL in 1 TRAY (65219-186-05) / 5 mL in 1 VIAL (65219-186-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "9acdebb0-6e88-42b2-ac45-da51aaad0f3c", "openfda": {"upc": ["0365219186014", "0365219184010", "0365219188018"], "unii": ["O18YUO0I83"], "rxcui": ["238082", "238083", "238084"], "spl_set_id": ["cc67b0fd-ca73-49f6-b5ca-705dc7331776"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 TRAY (65219-186-05) / 5 mL in 1 VIAL (65219-186-01)", "package_ndc": "65219-186-05", "marketing_start_date": "20250418"}], "brand_name": "ketamine hydrochloride", "product_id": "65219-186_9acdebb0-6e88-42b2-ac45-da51aaad0f3c", "dosage_form": "INJECTION", "pharm_class": ["General Anesthesia [PE]", "General Anesthetic [EPC]"], "product_ndc": "65219-186", "dea_schedule": "CIII", "generic_name": "ketamine hydrochloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ketamine hydrochloride", "active_ingredients": [{"name": "KETAMINE HYDROCHLORIDE", "strength": "100 mg/mL"}], "application_number": "ANDA215808", "marketing_category": "ANDA", "marketing_start_date": "20230710", "listing_expiration_date": "20261231"}